Faricimab Safe, Effective in Neovascular AMD

(MedPage Today) -- Both vision gains and disease control were sustained in all faricimab (Vabysmo) dosing cohorts among patients with neovascular age-related macular degeneration (AMD), according to research presented at the American Academy of...